BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  New Data From Phase II I-SPY 2 TRIAL Shows Improved Outcomes With Combination Of Merck & Co.’s KEYTRUDA (Pembrolizumab) Plus Standard Neoadjuvant Therapy In Patients With High-Risk Breast Cancer

  June 5, 2017

   · 

  3 min read
• NovoCure Release: Health Care Service Corporation Issues Positive Coverage Decision For Optune

  June 5, 2017

   · 

  5 min read
• Drug Development

  GlycoMimetics Presents Updated Data From Ongoing Phase I/II Clinical Trial Of GMI-1271 In Patients With Acute Myeloid Leukemia At ASCO 2017 Annual Meeting

  June 5, 2017

   · 

  6 min read
• FDA

  Becton, Dickinson and Company Nabs FDA Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea

  June 5, 2017

   · 

  3 min read
• Business

  Updated Data From ECHO-202 Trial Of Incyte’s Epacadostat In Combination With Merck & Co.’s KEYTRUDA (Pembrolizumab) Demonstrate Clinical Activity Across Multiple Tumor Types

  June 5, 2017

   · 

  1 min read
• Drug Development

  Novoteris, LLC Receives FDA And Health Canada Clearance To Start A Phase II Clinical Trial Of Its Thiolanox Nitric Oxide For The Treatment Of Cystic Fibrosis

  June 5, 2017

   · 

  3 min read
• Drug Development

  Helsinn And MEI Pharma Report Correlation Between Mutations In DNA Methylation Pathway And Clinical Response In Phase II Study Of Pracinostat And Azacitidine In Acute Myeloid Leukemia

  June 5, 2017

   · 

  8 min read
• Genetown

  SAGE Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  June 5, 2017

   · 

  1 min read
• Drug Development

  Zavante Therapeutics Reports ZOLYD Broad Spectrum Activity And Synergy With Multiple Antibiotics; In Vitro Studies Presented At ASM Microbe 2017 Meeting

  June 5, 2017

   · 

  6 min read
• FDA

  Bay Area’s Claret Medical Wins FDA Nod to Market Sentinel Cerebral Protection System in the U.S.

  June 5, 2017

   · 

  4 min read